Skip to main content
[Preprint]. 2024 Aug 13:2024.08.12.24311876. [Version 1] doi: 10.1101/2024.08.12.24311876

Table 2.

Longitudinal biomarker trajectories

Biomarker Increase per month, relative to baseline
Mean (95% CI) P-value
Serum NfL (pg/mL) 1 0.98% (0.57%, 1.38%) <0.0001

Serum pNfH (pg/mL) 1 0.45% (−0.12%, 1.03%) 0.12

Serum NfL/pNfH ratio 0.44% (−0.09%, 0.97%) 0.10

Urinary p75ECD (ng/mg creatinine) 2.59% (2.01%, 3.17%) <0.0001

Values are unadjusted for core clinical covariates

1

One substantial outlier, from the 18-month visit (i.e. visit 5) of a participant, was excluded.